Gould Capital, LLC

Position in MRK — Merck & Co., Inc.

CIK 1908965 TACOMA, WA

Position in MRK

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$3,760,552

+$267,812 QoQ

Shares Held

29,265

+0.8% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

2.82%

of 13F equity value

Holder Rank

#1,188

of 3,768 holders

Holding Since

Dec 2021

19 quarters on record

Voting authority Sole 10% Shared 0% None 90%

Healthcare · as of Jun 30, 2026

Gould Capital, LLC holds $5,361,370 across 4 Drug Manufacturers - General names. MRK ranks #1 (70.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRK	Merck & Co., Inc. This page	29,265	$3,760,552
2	GILD	Gilead Sciences, Inc.	12,259	$1,548,802
3	JNJ	Johnson & Johnson	110	$27,936
4	PFE	Pfizer Inc	1,000	$24,080

19 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,760,552	29,265	+0.8%	Shares	Sole	2026-08-07
2026-03-31	$3,492,740	29,036	-8.3%	Shares	Sole	2026-05-18
2025-12-31	$3,333,268	31,667	-0.8%	Shares	Sole	2026-02-13
2025-09-30	$2,679,549	31,926	+3.3%	Shares	Sole	2025-11-17
2025-06-30	$2,447,627	30,920	+3.7%	Shares	Sole	2025-08-14
2025-03-31	$2,676,104	29,814	+21.3%	Shares	Sole	2025-05-14
2024-12-31	$2,445,715	24,585	+0.9%	Shares	Sole	2025-02-21
2024-09-30	$2,767,230	24,368	-0.2%	Shares	Sole	2024-11-18
2024-06-30	$3,023,196	24,420	-2.3%	Shares	Sole	2024-08-15
2024-03-31	$3,298,750	25,000	+0.5%	Shares	Sole	2024-05-13
2023-12-31	$2,711,109	24,868	+1.1%	Shares	Sole	2024-02-15
2023-09-30	$2,533,187	24,606	-0.2%	Shares	Sole	2023-11-09
2023-06-30	$2,844,594	24,652	-3.6%	Shares	Sole	2023-08-25
2023-03-31	$2,719,328	25,560	-27.9%	Shares	Sole	2023-05-16
2022-12-31	$3,930,736	35,428	-4.4%	Shares	Sole	2023-02-14
2022-09-30	$3,190,573	37,048	-0.7%	Shares	Sole	2022-11-23
2022-06-30	$3,401,096	37,305	-2.1%	Shares	Sole	2022-08-03
2022-03-31	$3,125,940	38,098	+2.5%	Shares	Sole	2022-07-21
2021-12-31	$2,848,095	37,162	—	Shares	Sole	2022-02-14
No filing history on record for this holder in this stock.